Characterization of the human glycogenin-1 gene: Identification of a muscle-specific regulatory domain

The de-novo synthesis of glycogen is now known to involve a novel class of self-glucosylating protein primers. In mammalian skeletal muscle, glycogeni n-l is the protein responsible for this initiation step. Northern blot anal ysis revealed that glycogenin-l gene transcription is differentially regula ted in the C2C12 mouse muscle cell line. To define the regulatory elements that control expression of the glycogenin-l gene, we have cloned and charac terized the genomic structure of the human glycogenin-l gene and its promot er region. This gene consists of seven exons and six introns, and spans ove r 13 kb. Transcription of human glycogenin-l is initiated at two major site s, XO and 86 bp upstream from the initiation of translation codon. Nucleoti de sequence analysis of 2.1 kb of the 5'-flanking region revealed the proxi mal promoter contains both a TATA box and two putative Spl binding sites lo cated in a CpG island. There are numerous binding sites for developmental a nd cell-type-specific transcription factors, including AP-1, AP-2, GATA, an d several potential Oct 1 binding domains. There are also nine consensus E- boxes that bind the basic helix-loop-helix family of muscle-specific transc ription factors. The transcriptional activity of the glycogenin-l gene was investigated by transient transfection of the 5'-flanking region in HepG2 c ells and C2C12 myoblasts and myotubes. These results permitted the definiti on of a minimal 232 bp promoter fragment that is responsible for basal leve l transcription in a cell-type-independent manner. Furthermore, we have ide ntified a regulatory region located between -2076 and -1736 of the 5'-flank ing region of the human glycogenin-l gene that allows myotube-specific expr ession in C2C12 cells. (C) 1999 Elsevier Science B.V. All rights reserved.